Posttreatment but not pretreatment with selective β-adrenoreceptor 1 antagonists provides neuroprotection in the hippocampus in rats subjected to transient forebrain ischemia

Anesthesia and Analgesia

Volumn 110, Issue 4, 2010, Pages 1126-1132

  Iwata, Masato ^a   Inoue, Satoki ^a   Kawaguchi, Masahiko ^a   Nakamura, Mitsutoshi ^a   Konishi, Noboru ^a   Furuya, Hitoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENORECEPTOR 1 ANTAGONIST; ESMOLOL; ISOFLURANE; LANDIOLOL; PROPRANOLOL DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; HIPPOCAMPUS; HYPOTENSION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 77951015221     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181d278f7     Document Type: Article

References (27)

1. Standefer M, Little JR. Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol. Neurosurgery 1986;18:136-140 (Pubitemid 16161273)
2. Latchaw JP, Little JR, Slugg RM, Lesser RP, Stowe N. Treatment of acute focal cerebral ischemia and recirculation with d-propranolol. Neurosurgery 1985;16:18-22 (Pubitemid 15154196)
3. Capraro JA, Reedy DP, Latchaw JP, Slugg RM, Stowe NT, Lesser RP, Little JR. Treatment of acute focal cerebral ischemia with propranolol. Stroke 1984;15:486-491 (Pubitemid 14105962)
4. Little JR, Latchaw JP Jr, Slugg RM, Lesser RP, Stowe NT. Treatment of acute focal cerebral ischemia with propranolol. Stroke 1982;13:302-307 (Pubitemid 12107350)
5. Goyagi T, Kimura T, Nishikawa T, Tobe Y, Masaki Y. Betaadrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats. Anesth Analg 2006;103:658-663 (Pubitemid 44542920)
6. Semkova I, Schilling M, Henrich-Noack P, Rami A, Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 1996;717:44-54 (Pubitemid 26153435)
7. Semkova I, Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Rev 1999;30:176-188 (Pubitemid 29440940)
8. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke 1989;20:1627-1642 (Pubitemid 20030870)
9. Li H, Colbourne F, Sun P, Zhao Z, Buchan AM, Iadecola C. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke 2000;31:176-182 (Pubitemid 30035772)
10. Bond A, Ragumoorthy N, Monn JA, Hicks CA, Ward MA, Lodge D, O'Neill MJ. LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia. Neurosci Lett 1999;273:191-194 (Pubitemid 29430182)
11. Miura Y, Grocott HP, Bart RD, Pearlstein RD, Dexter F, Warner DS. Differential effects of anesthetic agents on outcome from near-complete but not incomplete global ischemia in the rat. Anesthesiology 1998;89:391-400 (Pubitemid 28373429)
12. Palkovits M, Brownstein MJ. Maps and Guide to Microdissection of the Rat Brain. New York, NY: Elsevier, 1980
13. Luchette FA, Robinson BR, Friend LA, McCarter F, Frame SB, James JH. Adrenergic antagonists reduce lactic acidosis in response to hemorrhagic shock. J Trauma 1999;46:873-880 (Pubitemid 29228127)
14. Le Tulzo Y, Shenkar R, Kaneko D, Moine P, Fantuzzi G, Dinarello CA, Abraham E. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. J Clin Invest 1997;99:1516-1524 (Pubitemid 27163802)
15. Raddatz A, Kubulus D, Winning J, Bauer I, Pradarutti S, Wolf B, Kreuer S, Rensing H. Dobutamine improves liver function after hemorrhagic shock through induction of heme oxygenase-1. Am J Respir Crit Care Med 2006;174:198-207 (Pubitemid 44015393)
16. Mackenzie ET, McCulloch J, Harper AM. Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiol 1976;231:483-488
17. Weksler BB, Gillick M, Pink J. Effects of propranolol on platelet function. Blood 1977;49:185-196
18. Braunwald E. Mechanism of action of calcium channel blocking agents. N Engl J Med 1982;307:1618-1627 (Pubitemid 13250421)
19. Lindemann JP, Bailev JC, Watanabe AM. Potential biochemical mechanisms for regulation of the slow inward current: theoretical basis for drug action. Am Heart J 1982;103:746-756
20. Van der hoek JY, Feinstein MB. Local anesthetics, chlorpromazine and propranolol inhibit stimulus activation of phospholipase A2 in human platelets. Mol Pharmacol 1978;16:171-180
21. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research group. N Engl J Med 1996;335:1713-1720 (Pubitemid 26399345)
22. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006;152:983-990 (Pubitemid 44632958)
23. Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C. Diabetic Postoperative Mortality and Morbidity group. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 2004;147:677-683 (Pubitemid 38900458)
24. POISE Study group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-1847
25. Quon CY, Stampfli HF. Biochemical properties of blood esmolol esterase. Drug Metab Dispos 1985;13:420-424
26. Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, Sakaki K, Hachiya K, Ichioka Y, Kawamura M. Development of a highly cardioselective ultra short-actingβ-blocker, ONO-1101. Chem Pharm Bull 1992;40:1462-1469
27. Soszynski D, Kozak W, Conn CA, Rudolph K, Kluger MJ. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology 1996;63:459-467 (Pubitemid 26138051)